Experience with fulvestrant acetate in castration-resistant prostate cancer patients von Blesa, J.M. Gasent, Candel, V. Alberola, Marco, V. Giner, Giner-Bosch, V., Pulla, M. Provencio, Canales, J.B. Laforga

Volltext

Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid von Borrás‐Blasco, J., Rosique‐Robles, D., Giner‐Marco, V., Galan‐Brotons, A., Casterá, E., Costa, S.

Volltext

Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current... von Almenar Cubells, D., Bosch Roig, C., Jiménez Orozco, E., Álvarez, R., Cuervo, J.M., Díaz Fernández, N., Sánchez Heras, A.B., Galán Brotons, A., Giner Marco, V., Codes M. De Villena, M.

Volltext

Neoadjuvant chemoradiotherapy in rectal cancer patients (pt) with oxaliplatin (Ox) and capecitabine (Cp): Results of a phase II trial von Gasent Blesa, J., Alberola Candel, V., Juan, O., Provencio Pulla, M., Giner Marco, V., Gravalos, C., Fernandez, I., Llorca, C.

Volltext

Phase II trial of second-line chemotherapy in metastatic pancreas cancer with the combination of oxaliplatin (Ox) and capecitabine (Cp) von Gasent Blesa, J., Alberola Candel, V., Giner Marco, V., Juan, O., Provencio Pulla, M., Llorca, C., Gravalos, C.

Volltext

Effect of the response to first-line chemotherapy (chemo) in the chemotherapy-induced anemia control with the administration of Erithropoyetins (Epos) in metastatic non-small cell... von Gasent Blesa, J., Giner Marco, V., Alberola Candel, V., Juan, O., Giner-Bosch, V., López, A., Provencio Pulla, M., Grande Pulido, E.

Volltext

A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer von Sculier, J. P., Lafitte, J. J., Lecomte, J., Berghmans, T., Thiriaux, J., Florin, M. C., Efremidis, A., Alexopoulos, C. G., Recloux, P., Ninane, V., Mommen, P., Paesmans, M., Klastersky, J.

Volltext

Osteonecrosis maxilar asociada a zoledronato von Borrás Blasco, J., Rosique Robles, D., Giner Marco, V., Galán Brotons, A.

Volltext

7049 Early results of a phase II trial of second line chemotherapy with oxaliplatin (Ox) and capecitabine (Cp) in hormonorresistant metastatic prostate cancer von Blesa, J. Gasent, Candel, V. Alberola, Vidal, O. Juan, Fuentes, P. Cerezuela, Marco, V. Giner

Volltext

7050 Evidence of psa decrease with fulvestrant acetate in androgen independent prostate cancer (AIPC) patients von Blesa, J. Gasent, Candel, V. Alberola, Vidal, O. Juan, Marco, V. Giner, Fuentes, P. Cerezuela

Volltext

Zoledronate-related maxillary osteonecrosis von Borrás Blasco, J, Rosique Robles, D, Giner Marco, V, Galán Brotons, A

Volltext

Experience with fulvestrant acetate in castration-resistant prostate cancer patients von Gasent Blesa, J. M, Alberola Candel, V, Giner Marco, V, Giner-Bosch, Vicent, Provencio Pulla, M, Laforga Canales, J. B

Volltext bestellen

Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid von Borrás-Blasco, J., Rosique-Robles, D., Giner-Marco, V., Galan-Brotons, A., Casterá, E., Costa, S.

Volltext